Abstract:Background: Sirtuin3 (SIRT3), a pivotal mitochondrial regulatory enzyme, protects cellular components in the central nervous system against oxidative and metabolic stress. However, its influence on cognitive functions, especially within the hippocampal neurons and the cognitive disruptions induced by sepsis, remains elusive. This study aimed to elucidate the direct impact of SIRT3 on neuronal health and its involvement in cognitive deficits following sepsis. Methods: Behavioral changes were evaluated using fear conditioning protocols in wild-type (WT) and SIRT3 deficient (Sirt3(-/-)) mouse models. SIRT3 expression levels were quantified in septic mice following intraperitoneal lipopolysaccharide (LPS) administration (LPS, 10 mg/kg). In cellular experiments, HT22 neuronal cells were exposed to LPS (1 mu g/mL) or conditioned media from LPS-stimulated BV2 microglial cells (Mi-sup). Western blot analysis was employed to assess the presence of synapse-related and mitochondrial apoptosis-associated proteins. Oxidative stress and mitochondrial membrane potential (MMP) were respectively performed with reactive oxygen species (ROS) staining and 5,5 ',6,6 '-tetrachloro1,1 ',3,3 '-tetraethylbenzimid azolocarbocyanine iodide (JC-1) staining. Mitochondrial p66Shc and c-Jun N-terminal kinase (JNK) phosphorylation levels were evaluated through western blotting and immunofluorescence assays. Results: Contextual and cued freezing durations were significantly shorter in Sirt3(-/-) mice than in wild-type counterparts (p < 0.05 and p < 0.01, respectively). Sirt3(-/-) mice exhibited a reduction in postsynaptic density protein 95 (PSD95) (p < 0.05) and an increase in brain-derived neurotrophic factor precursor (pro-BDNF) (p < 0.001). Sepsis led to a marked decrease in SIRT3 expression (p < 0.001) in mice. In cellular studies, the elevation of SIRT3 significantly increased PSD95 (p < 0.01), reduced pro-BDNF (p < 0.05), and enhanced the B-cell lymphoma 2/Bcl-2-associated X protein (Bcl-2/Bax) ratio (p < 0.05) while decreased cytochrome C release (p < 0.05) in Mi-sup-treated HT22 cells. Additionally, SIRT3 elevation reduced ROS production (p < 0.05) and enhanced MMP (p < 0.05). Mi-sup exposure was associated with elevated p-p66Shc/p66Shc and p-JNK/JNK ratio (p < 0.05 and p < 0.01). The activation of JNK/p66Shc was mitigated by either SIRT3 overexpression or the application of a JNK inhibitor (p < 0.01). Conclusion: SIRT3 deficiency contributes to cognitive impairment. SIRT3 expression was reduced in the hippocampus of septic mice, resulting in similar cognitive deficits. Mechanistically, the neuronal JNK/p66Shc activation contributed to SIRT3 deficiency-mediated synaptic dysfunction and mitochondrial apoptosis in response to microglia activation-induced inflammation and oxidative stress. Our findings provide new insights into the role of SIRT3 in cognitive function and its potential clinical significance in sepsis-induced cognitive impairment.

SIRT3 Protects Against Cognitive Dysfunction Induced by Sepsis-Associated Encephalopathy Via JNK/p66Shc-Regulated Mitochondrial Apoptosis in Mice

Neuronal SIRT3 Decline Mediates Sepsis-Associated Encephalopathy Through Microglia Activation

Sirt3 is a Novel Target to Treat Sepsis Induced Myocardial Dysfunction by Acetylated Modulation of Critical Enzymes Within Cardiac Tricarboxylic Acid Cycle

NLRP3/Caspase-1 Pathway-Induced Pyroptosis Mediated Cognitive Deficits in a Mouse Model of Sepsis-Associated Encephalopathy

Mitochondria-Targeted Peptide Reverses Mitochondrial Dysfunction and Cognitive Deficits in Sepsis-Associated Encephalopathy

SS-31 Improves Cognitive Function in Sepsis-Associated Encephalopathy by Inhibiting the Drp1-NLRP3 Inflammasome Activation.

Role of SIRT1 in sepsis-induced encephalopathy: Molecular targets for future therapies

Sirtuin 3 protects against anesthesia/surgery-induced cognitive decline in aged mice by suppressing hippocampal neuroinflammation

β-Nicotinamide mononucleotide activates NAD+/SIRT1 pathway and attenuates inflammatory and oxidative responses in the hippocampus regions of septic mice

SIRT3 Protects Against Early Brain Injury Following Subarachnoid Hemorrhage Via Promoting Mitochondrial Fusion in an AMPK Dependent Manner

3-Methyladenine attenuates neuroinflammation and improves cognitive function in sepsis-associated encephalopathy by inhibiting autophagy

The Role of SIRT3 in Mediating the Cognitive Deficits and Neuroinflammatory Changes Associated with a Developmental Animal Model of Schizophrenia

β-patchoulene alleviates cognitive dysfunction in a mouse model of sepsis associated encephalopathy by inhibition of microglia activation through Sirt1/Nrf2 signaling pathway

Resveratrol glycoside mediates microglial endoplasmic reticulum stress to mitigate LPS-induced sepsis-associated cognitive dysfunction

Ubiquitin-specific protease 8 regulates cognitive dysfunction of mice with sepsis-associated encephalopathy through SIRT1 deubiquitination

CD137L Inhibition Ameliorates Hippocampal Neuroinflammation and Behavioral Deficits in a Mouse Model of Sepsis-Associated Encephalopathy

Sirtuin 3 (SIRT3) improves sevoflurane-induced postoperative cognitive impairment by regulating mitochondrial oxidative stress

Sepsis-induced selective parvalbumin interneuron phenotype loss and cognitive impairments may be mediated by NADPH oxidase 2 activation in mice

CXCR5 down-regulation alleviates cognitive dysfunction in a mouse model of sepsis-associated encephalopathy: potential role of microglial autophagy and the p38MAPK/NF-κB/STAT3 signaling pathway

NU9056, a KAT 5 Inhibitor, Treatment Alleviates Brain Dysfunction by Inhibiting NLRP3 Inflammasome Activation, Affecting Gut Microbiota, and Derived Metabolites in LPS-Treated Mice

Disruption of Striatal-Enriched Protein Tyrosine Phosphatase Signaling Might Contribute to Memory Impairment in a Mouse Model of Sepsis-Associated Encephalopathy